Endocrine Testing Market Size, Share, Analysis, Trends, Growth, 2032

Endocrine Testing Market

Endocrine Testing Market By Tests (Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH),Estradiol (E2), Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), Testosterone, Thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and Other Test), By Technology (Monoclonal & Polyclonal Antibody Technologies, Tandem Mass Spectrometry, Immunoassay, Sensors, Clinical Chemistry Technologies, and Others), By End-user (Commercial Laboratories, Home-Based Tests, Ambulatory Care Centers, Hospitals, and Other Healthcare Settings): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032-

Category: Medical Device Report Format : PDF Pages: 120 Report Code: ZMR-385 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 2.33 Billion USD 4.78 Billion 8.3% 2023

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Tests
        • 2.1.1.2. Market Attractiveness Analysis, By Technology
        • 2.1.1.3. Market Attractiveness Analysis, By End-user
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Endocrine Testing Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Endocrine Testing Market – Tests Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Tests, 2020 & 2028
    • 4.2. Dehydroepiandrosterone sulfate (DHEAS)
      • 4.2.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Progesterone
      • 4.3.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Luteinizing Hormone (LH)
      • 4.4.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Estradiul (E2)
      • 4.5.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. Human Chorionic Gonadotropin (hCG), Fullicle Stimulating (FSH)
      • 4.6.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.7. Testosterone
      • 4.7.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.8. Thyroid prulactin
      • 4.8.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.8.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.9. Thyroid Stimulating Hormone (TSH), cortisul, insulin
      • 4.9.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.9.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.10. Other Test
      • 4.10.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.10.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.10.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5: Endocrine Testing Market – Technology Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Technology, 2020 & 2028
    • 5.2. Monoclonal & Pulyclonal Antibody Technulogies
      • 5.2.1. Market End-user and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Tandem Mass Spectrometry
      • 5.3.1. Market End-user and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Immunoassay
      • 5.4.1. Market End-user and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Sensors
      • 5.5.1. Market End-user and Forecast, By Region (USD Billion)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Clinical Chemistry Technulogies
      • 5.6.1. Market End-user and Forecast, By Region (USD Billion)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Others
      • 5.7.1. Market End-user and Forecast, By Region (USD Billion)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Endocrine Testing Market – End-user Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By End-user, 2020 & 2028
    • 6.2. Commercial Laboratories
      • 6.2.1. Market End-user and Forecast, By Region (USD Billion)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Home-Based Tests
      • 6.3.1. Market End-user and Forecast, By Region (USD Billion)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Ambulatory Care Centers
      • 6.4.1. Market End-user and Forecast, By Region (USD Billion)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.5. Hospitals
      • 6.4.1. Market End-user and Forecast, By Region (USD Billion)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.6. Other Healthcare Settings
      • 6.6.1. Market End-user and Forecast, By Region (USD Billion)
      • 6.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.6.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7 Endocrine Testing Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.2.2. North America Market Revenue, By Test, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Technology, 2016 – 2028
      • 7.2.4. North America Market Revenue, By End-user, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Test, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Technology, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By End-user, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Test, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Technology, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By End-user, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Test, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Technology, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By End-user, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.3.2. Europe Market Revenue, By Test, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Technology, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By End-user, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Test, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Technology, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By End-user, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Test, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Technology, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By End-user, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Test, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Technology, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By End-user, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Test, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Technology, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By End-user, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Test, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Technology, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By End-user, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Test, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Technology, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By End-user, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.4.2. Asia Pacific Market Revenue, By Test, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Technology, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By End-user, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Test, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Technology, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By End-user, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Test, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Technology, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By End-user, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Test, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Technology, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By End-user, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Test, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Technology, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By End-user, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Test, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Technology, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By End-user, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Test, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Technology, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By End-user, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.5.2. Latin America Market Revenue, By Test, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Technology, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By End-user, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Test, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Technology, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By End-user, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Test, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Technology, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By End-user, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Test, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Technology, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By End-user, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Test, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Technology, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By End-user, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Test, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Technology, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By End-user, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Test, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Technology, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By End-user, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Test, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Technology, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By End-user, 2016 – 2028
  • Chapter No. 8 Endocrine Testing Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Tests Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9 Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Endocrine Testing Market: Company Market Share, 2019
      • 9.1.2. Global Endocrine Testing Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 9.1.3. Global Endocrine Testing Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Endocrine Testing Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10: Company Profiles
    • 10.1. Bio Rad Laboratories
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. DIASORIN
    • 10.3. Hoffmann-La Roche Ltd.
    • 10.4. LabCorp
    • 10.5. Quest Diagnostics
    • 10.6. Abbott Laboratories
    • 10.7. AB Sciex
    • 10.8. Agilent Technulogies
    • 10.9. Biomedical Technulogies
    • 10.10. bioMerieux SA
  • Chapter No. 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Technology Change
  • Chapter No. 12 Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Tests
FIG NO. 2. Market Attractiveness Analysis, By Technology
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Endocrine Testing Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 7. Market Revenue Share, By Tests, 2020 & 2028
FIG NO. 8. Global Endocrine Testing Market for Dehydroepiandrosterone sulfate (DHEAS), Revenue (USD Billion) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Endocrine Testing Market for Dehydroepiandrosterone sulfate (DHEAS), By Country, 2020 & 2028
FIG NO. 10. Global Endocrine Testing Market for Progesterone, Revenue (USD Billion) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Endocrine Testing Market for Progesterone, By Country, 2020 & 2028
FIG NO. 12. Global Endocrine Testing Market for Luteinizing Hormone (LH), Revenue (USD Billion) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Endocrine Testing Market for Luteinizing Hormone (LH), By Country, 2020 & 2028
FIG NO. 14. Global Endocrine Testing Market for Estradiol (E2), Revenue (USD Billion) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Endocrine Testing Market for Estradiol (E2), By                              Country, 2020 & 2028
FIG NO. 16. Global Endocrine Testing Market for Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), Revenue (USD Billion) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Endocrine Testing Market for Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), By Country, 2020 & 2028
FIG NO. 18. Global Endocrine Testing Market for Testosterone, Revenue (USD Billion) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of Endocrine Testing Market for Testosterone, By       Country, 2020 & 2028
FIG NO. 20. Global Endocrine Testing Market for Thyroid prolactin, Revenue (USD Billion) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Endocrine Testing Market for Thyroid prolactin, By Country, 2020 & 2028
FIG NO. 22. Global Endocrine Testing Market for Thyroid Stimulating Hormone (TSH), cortisol, insulin, Revenue (USD Billion) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Endocrine Testing Market for Thyroid Stimulating Hormone (TSH), cortisol, insulin, By Country, 2020 & 2028
FIG NO. 24. Global Endocrine Testing Market for Other Test, Revenue (USD Billion) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Endocrine Testing Market for Other Test, By Country, 2020 & 2028
FIG NO. 26. Market Revenue Share, By Technology, 2020 & 2028
FIG NO. 27. Global Endocrine Testing Market for Monoclonal & Polyclonal Antibody Technologies, Revenue (USD Billion) 2016 – 2028
FIG NO. 28. Comparative Revenue Analysis of Endocrine Testing Market for Monoclonal & Polyclonal Antibody Technologies, By Country, 2020 & 2028
FIG NO. 29. Global Endocrine Testing Market for Tandem Mass Spectrometry, Revenue (USD Billion) 2016 – 2028
FIG NO. 30. Comparative Revenue Analysis of Endocrine Testing Market for Tandem Mass Spectrometry, By Country, 2020 & 2028
FIG NO. 31. Global Endocrine Testing Market for Immunoassay, Revenue (USD Billion) 2016 – 2028
FIG NO. 32. Comparative Revenue Analysis of Endocrine Testing Market for Immunoassay, By Country, 2020 & 2028
FIG NO. 33. Global Endocrine Testing Market for Sensors, Revenue (USD Billion) 2016 – 2028
FIG NO. 34. Comparative Revenue Analysis of Endocrine Testing Market for Sensors, By Country, 2020 & 2028
FIG NO. 35. Global Endocrine Testing Market for Clinical Chemistry Technologies, Revenue (USD Billion) 2016 – 2028
FIG NO. 36. Comparative Revenue Analysis of Endocrine Testing Market for Clinical Chemistry Technologies, By Country, 2020 & 2028
FIG NO. 37. Global Endocrine Testing Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 38. Comparative Revenue Analysis of Endocrine Testing Market for Others, By Country, 2020 & 2028
FIG NO. 39. Market Revenue Share, By End-user, 2020 & 2028
FIG NO. 40. Global Endocrine Testing Market for Commercial Laboratories, Revenue (USD Billion) 2016 – 2028
FIG NO. 41. Comparative Revenue Analysis of Endocrine Testing Market for Commercial Laboratories, By Country, 2020 & 2028
FIG NO. 42. Global Endocrine Testing Market for Home-Based Tests, Revenue (USD Billion) 2016 – 2028
FIG NO. 43. Comparative Revenue Analysis of Endocrine Testing Market for Home-Based Tests, By Country, 2020 & 2028
FIG NO. 44. Global Endocrine Testing Market for Ambulatory Care Centers, Revenue (USD Billion) 2016 – 2028
FIG NO. 45. Comparative Revenue Analysis of Endocrine Testing Market for Ambulatory Care Centers, By Country, 2020 & 2028
FIG NO. 46. Global Endocrine Testing Market for Hospitals, Revenue (USD Billion) 2016 – 2028
FIG NO. 47. Comparative Revenue Analysis of Endocrine Testing Market for Hospitals, By Country, 2020 & 2028
FIG NO. 48. Global Endocrine Testing Market for Other Healthcare Settings, Revenue (USD Billion) 2016 – 2028
FIG NO. 49. Comparative Revenue Analysis of Endocrine Testing Market for Other Healthcare Settings, By Country, 2020 & 2028
FIG NO. 50. Global Endocrine Testing Market Revenue Share, By Region, 2020 & 2028
FIG NO. 51. North America Endocrine Testing Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 52. Porter’s Five Forces Analysis for Global Endocrine Testing Market
FIG NO. 53. PEST Analysis for Global Endocrine Testing Market
FIG NO. 54. Pricing Analysis for Global Endocrine Testing Market
FIG NO. 55. Value Chain Analysis for Global Endocrine Testing Market
FIG NO. 56. Company Share Analysis, 2019
FIG NO. 57. Radar Determinant Chart, 2019
FIG NO. 58. Company Strategic Developments – Heat Map Analysis
FIG NO. 59. Bio Rad Laboratories Business Segment Revenue Share, 2020 (%)
FIG NO. 60. Bio Rad Laboratories Geographical Segment Revenue Share, 2020 (%)
FIG NO. 61. Market Channels
FIG NO. 62. Marketing Channel Development Trend
FIG NO. 63. Growth in World Gross Product, 2008-2018
FIG NO. 64. Research Methodology – Detailed View
FIG NO. 65. Research Methodology


Table Of Tables

List of Tables 

TABLE NO. 1. Global Endocrine Testing Market: Snapshot
TABLE NO. 2. Quarterly Endocrine Testing Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Endocrine Testing Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
TABLE NO. 6. Global Endocrine Testing Market for Dehydroepiandrosterone sulfate (DHEAS), by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Endocrine Testing Market for Progesterone, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Endocrine Testing Market for Luteinizing Hormone (LH), by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Endocrine Testing Market for Estradiol (E2), by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Endocrine Testing Market for Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11. Global Endocrine Testing Market for Testosterone, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. Global Endocrine Testing Market for Thyroid prolactin, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13. Global Endocrine Testing Market for Thyroid Stimulating Hormone (TSH), cortisol, insulin, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 14. Global Endocrine Testing Market for Other Test, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 15. Global Endocrine Testing Market for Monoclonal & Polyclonal Antibody Technologies, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 16. Global Endocrine Testing Market for Tandem Mass Spectrometry, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 17. Global Endocrine Testing Market for Immunoassay, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 18.: Global Endocrine Testing Market for Sensors, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 19. Global Endocrine Testing Market for Clinical Chemistry Technologies, by Region, 2016 – 2028 (USD Billion)
TABLE NO.20. Global Endocrine Testing Market for Others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 21. Global Endocrine Testing Market for Commercial Laboratories, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 22. Global Endocrine Testing Market for Home-Based Tests, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 23. Global Endocrine Testing Market for Ambulatory Care Centers, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 24. Global Endocrine Testing Market for Hospitals, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 25. Global Endocrine Testing Market for Other Healthcare Settings, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 26. Global Endocrine Testing Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 27. North America Endocrine Testing Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 28. North America Endocrine Testing Market Revenue, By Tests, 2016 – 2028 (USD Billion)
TABLE NO. 29. North America Endocrine Testing Market Revenue, By Technology, 2016 – 2028 (USD Billion)
TABLE NO. 30. North America Endocrine Testing Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 31. U.S. Endocrine Testing Market Revenue, By Tests, 2016 – 2028 (USD Billion)
TABLE NO. 32. U.S. Endocrine Testing Market Revenue, By Technology, 2016 – 2028 (USD Billion)
TABLE NO. 33. U.S. Endocrine Testing Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 34. Canada Endocrine Testing Market Revenue, By Tests, 2016 – 2028 (USD Billion)
TABLE NO. 35. Canada Endocrine Testing Market Revenue, By Technology, 2016 – 2028 (USD Billion)
TABLE NO. 36. Canada Endocrine Testing Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 37. Mexico Endocrine Testing Market Revenue, By Tests, 2016 – 2028 (USD Billion) 
TABLE NO. 38. Mexico Endocrine Testing Market Revenue, By Technology, 2016 – 2028 (USD Billion)
TABLE NO. 39. Mexico Endocrine Testing Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 40. Drivers for the Endocrine Testing Market: Impact Analysis
TABLE NO. 41. Restraints for the Endocrine Testing Market: Impact Analysis
TABLE NO. 42. Major Buyers of Endocrine Testing 
TABLE NO. 43. Distributors/Traders List of Endocrine Testing 
TABLE NO. 44. Global Endocrine Testing Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 45. Global Endocrine Testing Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)
  
 

Methodology

FrequentlyAsked Questions

The global Endocrine Testing market was valued at USD 2.33 Billion in 2023.

The global Endocrine Testing market is expected to reach USD 4.78 Billion by 2032, growing at a CAGR of 8.3% between 2024 to 2032.

Some of the key factors driving the global Endocrine Testing market growth are rising health issues across the globe.

North America Endocrine Testing market is expected to show strong growth on account of growing technological spending and facilities.

The major players operating in the Endocrine Testing market are Bio Rad Laboratories, DIASORIN, Hoffmann-La Roche Ltd., LabCorp, Quest Diagnostics, Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, and bioMerieux SA, among others.

Choose License Type

  • zion payment modes

List of Contents

Market InsightsMarket:OverviewCOVID-19 Impact AnalysisGrowth Factors Report ScopeSegment Analysis Preview Competitive LandscapeThe global market is segmented as follows:

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed